Stockscreener 앱 받기
10.86
1.09%
-0.12
시장 영업 전:
11.50
0.64
+5.89%
Carlsmed Inc 주식(CARL)의 최신 뉴스
Carlsmed Poised for Positive Growth Trajectory - San Diego Business Journal
Carlsmed joins Russell 2000 Index following Q3 IPO - MSN
Head-To-Head Comparison: Carlsmed (CARL) vs. Its Rivals - Defense World
Comparing Carlsmed (CARL) & The Competition - Defense World
Head to Head Review: Carlsmed (CARL) and The Competition - Defense World
Top Carlsmed (CARL) Competitors 2026 - MarketBeat
Carlsmed Earnings Call Highlights Rapid Growth, Rising Costs - TipRanks
Carlsmed Stock Down 6% Since IPO But Goldman Bullish And Predicts 35% Upside Potential — Retail Traders Stay Bearish - MSN
Carlsmed (CARL) versus The Competition Head to Head Analysis - Defense World
Carlsmed unveils custom cervical plating tech - MSN
Carlsmed (CARL) vs. Its Peers Financial Survey - Defense World
Carlsmed Unveils Personalized Spine Platform, Targets $70M-$75.5M 2025 Revenue at Conference - Defense World
Contrasting Carlsmed (CARL) & Its Peers - Defense World
Carlsmed (CARL) vs. Its Competitors Head-To-Head Contrast - Defense World
Carlsmed (CARL) versus The Competition Financial Contrast - Defense World
CARLSMED CEO Michael Cordonnier Sells Shares - TradingView
Contrasting Carlsmed (CARL) & Its Rivals - Defense World
CARL: Personalized spine surgery platform posts 86% annual growth and expands into cervical market - TradingView
CARL: Personalized spine surgery platform drives rapid growth, clinical success, and strong reimbursement - TradingView
Carlsmed (CARL) vs. Its Rivals Critical Survey - Defense World
Brokerages Set Carlsmed, Inc. (NASDAQ:CARL) Target Price at $21.33 - Defense World
Carlsmed (CARL) versus Its Peers Financial Contrast - Defense World
Carlsmed (NASDAQ:CARL) Cut to “Strong Sell” at Zacks Research - Defense World
Analysts Offer Insights on Healthcare Companies: Addus Homecare (ADUS), Wave Life Sciences (WVE) and Carlsmed, Inc. (CARL) - The Globe and Mail
Carlsmed, Inc. (NASDAQ:CARL) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Carlsmed (NASDAQ:CARL) Lowered to Strong Sell Rating by Zacks Research - MarketBeat
Head to Head Survey: Carlsmed (CARL) versus Its Competitors - Defense World
Carlsmed (CARL) Revenue Growth At 85.9% Tests Bearish Profitability Narratives - simplywall.st
Carlsmed Q4 2025 revenue up 61% to USD 15.2M - Medical Buyer
Carlsmed Q4 Earnings Call Highlights - MarketBeat
Carlsmed, Inc. Reports Strong Q4 2025 Earnings and Growth Outlook - Intellectia AI
Carlsmed Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Carlsmed Inc (NASDAQ:CARL) Reports Q4 Revenue Beat and Narrower-Than-Expected Loss - ChartMill
Earnings call transcript: Carlsmed reports strong revenue, stock dips Q4 2025 - Investing.com
Carlsmed (NASDAQ:CARL) Issues Quarterly Earnings Results - MarketBeat
CARL: 2025 revenue surged 86% with expanding margins and strong adoption of new spine surgery products - TradingView
CARL: 2025 revenue surged 86% with expanding margins; 2026 guidance targets $70–$75M and robust growth - TradingView
Carlsmed® Reports Fourth Quarter and Full Year 2025 Financial Results - The Manila Times
Carlsmed, Inc. Provides Revenue Guidance for the Year 2026 - marketscreener.com
Head to Head Comparison: Carlsmed (CARL) versus Its Competitors - Defense World
Carlsmed Inc (CARL) Q4 2025 Earnings Call Highlights: Record Revenue Growth Amidst Financial ... By GuruFocus - Investing.com Canada
Carlsmed announces clinical debuts of two spinal surgery solutions - Today's Medical Developments
Carlsmed Reports Fourth Quarter and Full Year 2025 Financial Results - Bitget
Carlsmed Unveils Custom Cervical Plating Tech - National Today
Carlsmed, Inc. To Participate in the 2026 Canaccord Genuity Musculoskeletal Conference - The Manila Times
Carlsmed Inc expected to post a loss of 43 cents a shareEarnings Preview - TradingView
Head to Head Survey: Carlsmed (NASDAQ:CARL) & Check-Cap (NASDAQ:MBAI) - Defense World
Financial Contrast: Carlsmed (CARL) and Its Competitors - Defense World
Carlsmed Announces first corra™ personalized Cervical Plating Procedure - Orthopedics This Week
Carlsmed Announces first corra personalized Cervical Plating Procedure - Bitget
Carlsmed (CARL) versus Its Competitors Financial Review - Defense World
Analyzing Carlsmed (CARL) & Its Competitors - Defense World
CARL Should I Buy - Intellectia AI
Wall Street Zen Upgrades Carlsmed (NASDAQ:CARL) to “Hold” - Defense World
Financial Review: Carlsmed (CARL) versus Its Rivals - Defense World
Critical Comparison: Carlsmed (NASDAQ:CARL) vs. TransEnterix (OTCMKTS:TRXDW) - Defense World
Carlsmed Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026 - The Manila Times
5.94%
자본화:
|
볼륨(24시간):